Clinical Trial Update: Efficacy/Effectiveness, Safety, and Immunogenicity of LC16m8 Mpox Vaccine in Colombia [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 trial in Colombia evaluating the efficacy, safety, and immunogenicity of the LC16m8 Mpox vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monkeypox

Drugs mentioned

• LC16m8 Mpox Vaccine (LC16m8 vaccinia-based vaccine)

Snippet

Sponsor: Universidad Nacional de Colombia | Conditions: Monkeypox | Phase 3 | Status: ACTIVE_NOT_RECRUITING